Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre-Régis Burgel

Showing results (61-70 of 251) with videos related to

Pageof 26
Sort By:
Respiratory Research|June 29, 2018
An attempt at modeling COPD epidemiological trends in FrancePierre-Régis Burgel, Caroline Laurendeau, Chantal Raherison, et al.
Frontiers in Cellular and Infection Microbiology|July 18, 2017
Harnessing Neutrophil Survival Mechanisms during Chronic Infection by <i>Pseudomonas aeruginosa</i>: Novel Therapeutic Targets to Dampen Inflammation in Cystic FibrosisBenoît S Marteyn, Pierre-Régis Burgel, Laurent Meijer, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2021
Reply to Kuek <i>et al.</i>: Optimism with Caution: Elexacaftor-Tezacaftor-Ivacaftor in Patients with Advanced Pulmonary DiseasePierre-Régis Burgel, Jennifer Da Silva, Jean-Louis Paillasseur, et al.
Investigational New Drugs|December 29, 2010
Everolimus-related organizing pneumonia: a report establishing causalityJustine Frija, Dominique Joly, Bertrand Knebelmann, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 4, 2016
Exacerbations of COPDIan D Pavord, Paul W Jones, Pierre-Régis Burgel, et al.
BMC Pulmonary Medicine|July 14, 2019
Randomized controlled trials of pharmacological treatments to prevent COPD exacerbations: applicability to real-life patientsLaurie Pahus, Pierre-Régis Burgel, Nicolas Roche, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 11, 2024
Exploring the Role of Tertiary Lymphoid Structures Using a Mouse Model of Bacteria-Infected LungsJean-Luc Teillaud, Lucile Regard, Clémence Martin, et al.
The European Respiratory Journal|May 28, 2016
Long-term computed tomographic changes in cystic fibrosis patients treated with ivacaftorGuillaume Chassagnon, Dominique Hubert, Isabelle Fajac, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 25, 2018
Exploring the Role of Tertiary Lymphoid Structures Using a Mouse Model of Bacteria-Infected LungsJean-Luc Teillaud, Lucile Regard, Clémence Martin, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 9, 2025
CFTR modulators and pregnancy outcomes: Early findings from a nationwide cohort studyLaurent Chouchana, Mathis Collier, Clémence Martin, et al.
Pageof 26

Showing results (61-70 of 251) with videos related to

Sort By:
Pageof 26
Respiratory Research|June 29, 2018
An attempt at modeling COPD epidemiological trends in FrancePierre-Régis Burgel, Caroline Laurendeau, Chantal Raherison, et al.
Frontiers in Cellular and Infection Microbiology|July 18, 2017
Harnessing Neutrophil Survival Mechanisms during Chronic Infection by <i>Pseudomonas aeruginosa</i>: Novel Therapeutic Targets to Dampen Inflammation in Cystic FibrosisBenoît S Marteyn, Pierre-Régis Burgel, Laurent Meijer, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2021
Reply to Kuek <i>et al.</i>: Optimism with Caution: Elexacaftor-Tezacaftor-Ivacaftor in Patients with Advanced Pulmonary DiseasePierre-Régis Burgel, Jennifer Da Silva, Jean-Louis Paillasseur, et al.
Investigational New Drugs|December 29, 2010
Everolimus-related organizing pneumonia: a report establishing causalityJustine Frija, Dominique Joly, Bertrand Knebelmann, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 4, 2016
Exacerbations of COPDIan D Pavord, Paul W Jones, Pierre-Régis Burgel, et al.
BMC Pulmonary Medicine|July 14, 2019
Randomized controlled trials of pharmacological treatments to prevent COPD exacerbations: applicability to real-life patientsLaurie Pahus, Pierre-Régis Burgel, Nicolas Roche, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 11, 2024
Exploring the Role of Tertiary Lymphoid Structures Using a Mouse Model of Bacteria-Infected LungsJean-Luc Teillaud, Lucile Regard, Clémence Martin, et al.
The European Respiratory Journal|May 28, 2016
Long-term computed tomographic changes in cystic fibrosis patients treated with ivacaftorGuillaume Chassagnon, Dominique Hubert, Isabelle Fajac, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 25, 2018
Exploring the Role of Tertiary Lymphoid Structures Using a Mouse Model of Bacteria-Infected LungsJean-Luc Teillaud, Lucile Regard, Clémence Martin, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 9, 2025
CFTR modulators and pregnancy outcomes: Early findings from a nationwide cohort studyLaurent Chouchana, Mathis Collier, Clémence Martin, et al.
Pageof 26